Page last updated: 2024-08-23

triamcinolone and Encephalitis

triamcinolone has been researched along with Encephalitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cho, GJ; Choi, MY; Choi, WS; Chung, IY; Kang, SS; Kim, YH; Kim, YS; Lee, JH; Park, CH; Roh, GS; Yoo, JM	1
Eisen, AA; Norris, JW	1

Reviews

1 review(s) available for triamcinolone and Encephalitis

Article	Year
Adrenal steroid therapy in neurological disease. Part I. Canadian Medical Association journal, 1969, Jan-04, Volume: 100, Issue:1 Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Arteritis; Arthritis, Rheumatoid; Collagen Diseases; Dermatomyositis; Encephalitis; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Haplorhini; Humans; Lupus Erythematosus, Systemic; Multiple Sclerosis; Myasthenia Gravis; Myositis; Nervous System Diseases; Neurologic Manifestations; Paramethasone; Polyarteritis Nodosa; Polymyalgia Rheumatica; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sarcoidosis; Scleroderma, Systemic; Triamcinolone	1969

Article

Year

Adrenal steroid therapy in neurological disease. Part I.

Canadian Medical Association journal, 1969, Jan-04, Volume: 100, Issue:1

Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Arteritis; Arthritis, Rheumatoid; Collagen Diseases; Dermatomyositis; Encephalitis; Encephalomyelitis; Encephalomyelitis, Autoimmune, Experimental; Haplorhini; Humans; Lupus Erythematosus, Systemic; Multiple Sclerosis; Myasthenia Gravis; Myositis; Nervous System Diseases; Neurologic Manifestations; Paramethasone; Polyarteritis Nodosa; Polymyalgia Rheumatica; Prednisone; Purpura, Thrombotic Thrombocytopenic; Sarcoidosis; Scleroderma, Systemic; Triamcinolone

1969

Other Studies

1 other study(ies) available for triamcinolone and Encephalitis

Article	Year
Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia. Neurobiology of disease, 2007, Volume: 26, Issue:3 Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Body Weight; Cytokines; Disease Models, Animal; Encephalitis; Female; Gene Expression Regulation; Hyperoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Retinal Artery; Retinal Diseases; Signal Transduction; Triamcinolone; Vascular Endothelial Growth Factor A	2007

Article

Year

Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.

Neurobiology of disease, 2007, Volume: 26, Issue:3

Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Body Weight; Cytokines; Disease Models, Animal; Encephalitis; Female; Gene Expression Regulation; Hyperoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Retinal Artery; Retinal Diseases; Signal Transduction; Triamcinolone; Vascular Endothelial Growth Factor A

2007